U.S. federal trademark · Serial No. 99165346
Biotechnological gene therapy, nucleic acid drug and protein delivery platform technology for loading, targeting, and enhancing secretomes, extracellular vesicles (EVs) and exosomes across gene therapy, RNA medicine, and protein therapeutics
Design, development and operation of gene therapy, nucleic acid drug and protein delivery platform technology for scientific and medical research and development to help pharmaceutical companies deliver proteins, antibodies, small molecule inhibitors, nucleic acid medicines, vaccines, gene silencing and gene editing
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.